Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v5-EN
Language French English
Date Updated 2020-05-29 2020-04-02
Drug Identification Number 01926934 01926934
Brand name TEVA-SALBUTAMOL STERINEBS P.F. TEVA-SALBUTAMOL STERINEBS P.F.
Common or Proper name SALBUTAMOL 1MG/ML NEBS SALBUTAMOL 1MG/ML NEBS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION
Packaging size 2.5ml 2.5ml
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-06 2020-02-06
Estimated end date 2020-06-30 2020-07-31
Actual end date 2020-05-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Allocating to 100% of our market.
Health Canada comments